Small-Cap REIT ETF ...
Health Care: Health Services
Thoratec Corporation (THOR: NASDAQ)
$32.60 -0.63 | -1.90%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 56.16M | 71.54M | 59.00M | 28.58M |
| Operating Gains/Losses | 180.00K | 127.00K | 99.00K | 233.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -10.69M | -1.48M | -10.38M | -10.67M |
| (Increase) Decrease in Inventories | 5.20M | 6.66M | -18.93M | -7.76M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 6.34M | -1.60M | 7.34M | -2.14M |
| (Decrease) Increase In Other Current Liabilities | 2.24M | -1.07M | -1.63M | 6.64M |
| (Increase) Decrease In Other Working Capital | 13.93M | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 71.55M | 21.37M | 25.78M | 23.54M |
| Net Cash From Continuing Operations | 139.54M | 112.11M | 73.98M | 49.07M |
| Net Cash From Discontinued Operations | 0.00 | -1.40M | 357.00K | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 139.54M | 110.71M | 74.34M | 49.07M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 183.77M | 524.29M | 0.00 | 215.73M |
| Purchases of Property, Plant & Equipment | -10.72M | -6.21M | -5.66M | -13.26M |
| Acquisitions | -3.05M | -109.98M | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -181.04M | -281.83M | -572.25M | -346.72M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 3.00M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -11.04M | 126.27M | -69.21M | -141.25M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 13.58M | 14.60M | 26.27M | 12.08M |
| Repayment of Long-Term Debt | 0.00 | -164.43M | -5.36M | 0.00 |
| Repurchase of Capital Stock | -85.50M | -103.88M | -6.29M | -3.51M |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 1.73M | 1.66M | 9.46M | 3.15M |
| Net Cash From Financing Activities | -70.19M | -252.05M | 24.09M | 11.73M |
| Effect of Exchange Rate Changes | 358.00K | 847.00K | -119.00K | -144.00K |
| Net Change in Cash & Cash Equivalents | 58.66M | -14.23M | 29.10M | -80.59M |
Portfolios with THOR
- Portfolio NameUser Type
- Usermy portfolio
- ContributorStocks Rising On Unusual Vo...
- ContributorMost-Searched Stocks for th...
- ContributorBreakout Stocks Of The Week...
- Contributor10 Health Care Stocks With ...
- UserAberian System, MEDICAL stocks
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE Top 10 Best-Rate...
- UserJust Lookin'
- UserPART 5 JPMorgan 28th Annual...
Latest THOR Headlines from TheStreet
- 4 Stocks Dragging The Health Services Industry Downward 05.03.13 | 01:05 pm
- THOR Makes Notable Cross Below Critical Moving Average 04.18.13 | 11:04 am
- 8 Stocks Climbing Higher on Unusual Volume 11.21.12 | 02:11 pm
- Sunshine Heart: A Promising Treatment for Heart Failure Patients 11.05.12 | 08:11 am
- Analysts' Actions: TXN HAL DFS CELG THOR 10.03.12 | 10:10 am
- Thoratec's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.01.12 | 11:08 pm
- Thoratec's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.01.12 | 11:05 pm
- 7 Hot Stocks on Traders' Radars 04.05.12 | 11:04 am
- Analysts' Actions: CSCO, MMM, CIT, AMGN, S 02.09.12 | 09:02 am
- Thoratec Stock Gaps Up On Today's Open (THOR) 02.09.12 | 08:02 am
Press Releases for THOR
- Thoratec Presentation At Bank Of America Merrill Lynch 2013 Health Care Conference To Be Webcast - PR Newswire 05.14.13 | 09:05 am
- Thoratec Schedules First Quarter Conference Call, Webcast - PR Newswire 04.22.13 | 03:04 pm
- Meet Ms. Joe Ann Bivins, The World's Longest-Supported Recipient Of A Single Heart Assist Device - PR Newswire 03.19.13 | 09:03 am
- Thoratec Announces The First Human Use Of HeartMate PHPâ¿¢ - PR Newswire 03.18.13 | 08:03 am
- Thoratec Presentation At Barclays Global Healthcare Conference To Be Webcast - PR Newswire 03.11.13 | 04:03 pm
- Thoratec Presentation At Leerink Swann Global Healthcare Conference To Be Webcast - PR Newswire 02.11.13 | 08:02 am
- Thoratec Schedules Fourth Quarter Conference Call, Webcast - PR Newswire 01.28.13 | 09:01 am
- Thoratec Announces FDA Approval To Commence REVIVE-IT Study Utilizing HeartMate II® - PR Newswire 01.07.13 | 08:01 am
- Thoratec Presentation At J.P. Morgan Healthcare Conference To Be Webcast - PR Newswire 01.03.13 | 08:01 am
- Thoratec Announces Approval For HeartMate II® In Japan - PR Newswire 12.11.12 | 08:12 am
Partner Headlines for THOR
- Bull of the Day: Thoratec Corp. (THOR) - Bull of the Day - Zacks 12.07.12 | 01:12 am
- Stocks Hold Modest Gains; Stratasys Breaks Out - Investor's Business Daily 11.21.12 | 01:11 pm
- Thoratec Achieves 52-Week High - Analyst Blog - Zacks 11.05.12 | 06:11 pm
- Heart Failure: 'New Epidemic' Creates New Opportunities For Investors - Seeking Alpha 11.04.12 | 08:11 am
- Abiomed Beats 2Q Ests, Profit Jumps - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Thoratec Corporation (THOR) - Bull of the Day - Zacks 10.10.12 | 01:10 am
- FDA Approves Abiomed's Impella CP - Analyst Blog - NASDAQ 09.11.12 | 11:09 pm
- FDA Approves Abiomed's Impella CP - Analyst Blog - Zacks 09.11.12 | 07:09 pm
- 3 Healthcare Stocks With Positive Momentum - Seeking Alpha 09.01.12 | 08:09 am
- Abiomed Reaffirmed at Neutral - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
